Leiden, The Netherlands (June 4, 2010) - Dutch biopharmaceutical company Crucell N.V. (Euronext, Nasdaq: CRXL; Swiss Exchange: CRX) today announced that the Annual General Meeting of Shareholders (AGM) held today in Leiden adopted the 2009 financial statements. In addition, the AGM reappointed Mr. J.P. Oosterveld as member of the Supervisory Board; Mr. W. Burns, Mr. J. Shannon and Mr. G. Siber were appointed as new members of the Supervisory Board.
The shareholders of Crucell were represented in person, by proxy voting, or by voting instruction, representing a total of 36,2% of the total issued share capital entitled to vote.
The shareholders approved the appointments of Mr. William Burns, Mr. James Shannon and Mr. George Siber as members of the Supervisory Board. The appointments are for a term of four years, until 2014. The Chairman of the Supervisory Board, Mr. Jan Pieter Oosterveld was reappointed for a term of four years by Crucell's shareholders.
Furthermore the AGM approved the 2009 financial statements and all other resolutions.
At the meeting, presided by Jan Oosterveld, Chairman of the Supervisory Board, Ronald Brus, CEO of Crucell and Leon Kruimer, CFO discussed the company's 2009 results, reiterated the outlook for 2010 [1], and presented their views on the business and strategy of the company to shareholders. The slides of the presentation given at the AGM are available on the company's website www.crucell.com